Taha Masoumeh Fakhr, Valojerdi Mojtaba Rezazadeh
Department of Anatomy, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Int J Cardiol. 2008 Jun 23;127(1):78-87. doi: 10.1016/j.ijcard.2007.04.173. Epub 2007 Aug 21.
In spite of previous reports, the precise role of bone morphogenetic proteins (BMPs) on cardiomyocyte differentiation, especially in the absence or presence of minimum amount of serum in culture medium is still unclear. So, the aim of the present study was to investigate the effect of BMP-4 on mouse embryonic stem cells (ESCs)-derived cardiomyocyte differentiation in serum-free and low-serum media. The mouse ESCs differentiation to cardiomyocytes was induced by embryoid bodies' (EBs') development through hanging drop, suspension and plating stages. Different models of differentiation were designed according to addition of fetal bovine serum (FBS) or knockout serum replacement (KoSR) to the medium of three stages. 10 ng/ml BMP-4 was added throughout the suspension period. Up to 30 days after plating, contraction and beating frequency were monitored and evaluated daily. The growth characteristics of cardiomyocytes were assessed by cardioactive drugs, immunocytochemistry, transmission electron microscopy (TEM) and reverse transcription-polymerase chain reaction (RT-PCR). In the complete absence of serum, neither control nor BMP-4 treated groups resulted in cardiac differentiation. Addition of FBS to hanging drop stage resulted in the appearance of beating cardiac clusters in some BMP-4 treated EBs. In the best designed differentiation model in which only hanging drop and the first 24 h of plating stage was carried out at the presence of FBS, the BMP-4 treatment resulted in cardiac differentiation in EBs characterized by positive immunostaining for the applied antibodies, chronotropic response to the cardioactive drugs and cardiac-specific genes expression at different developmental stages. These cardiomyocytes showed immature myofibrils and numerous intercellular junctions. In conclusion, BMP-4 is unable to induce cardiomyocyte differentiation from mouse ESCs in serum-free models, and at least small amount of FBS in hanging drop stage is necessary. Furthermore, serum factors are not strictly necessary after the initial activation, but they do favor a better differentiation of cardiomyocytes.
尽管此前已有相关报道,但骨形态发生蛋白(BMPs)在心肌细胞分化过程中的精确作用仍不清楚,尤其是在培养基中血清含量极少或无血清的情况下。因此,本研究旨在探讨BMP-4在无血清和低血清培养基中对小鼠胚胎干细胞(ESCs)分化为心肌细胞的影响。通过悬滴、悬浮和平板培养阶段诱导胚胎体(EBs)发育,从而促使小鼠ESCs分化为心肌细胞。根据在三个阶段的培养基中添加胎牛血清(FBS)或敲除血清替代物(KoSR)设计了不同的分化模型。在整个悬浮培养期间添加10 ng/ml BMP-4。平板接种后长达30天,每天监测并评估收缩情况和搏动频率。通过心脏活性药物、免疫细胞化学、透射电子显微镜(TEM)和逆转录聚合酶链反应(RT-PCR)评估心肌细胞的生长特性。在完全无血清的情况下,对照组和BMP-4处理组均未发生心脏分化。在悬滴阶段添加FBS后,一些经BMP-4处理的EBs中出现了搏动的心脏细胞团。在最佳设计的分化模型中,仅在悬滴阶段和接种阶段的前24小时存在FBS,BMP-4处理导致EBs发生心脏分化,其特征为对所用抗体呈阳性免疫染色、对心脏活性药物有变时反应以及在不同发育阶段表达心脏特异性基因。这些心肌细胞显示出不成熟的肌原纤维和大量细胞间连接。总之,在无血清模型中,BMP-4无法诱导小鼠ESCs分化为心肌细胞,悬滴阶段至少需要少量FBS。此外,在初始激活后血清因子并非严格必需,但它们确实有利于心肌细胞更好地分化。